Pilot Trial to Assess the Performance and Tolerance of mRDX-02-17 Dermal Filler in the Facial Rejuvenation

NCT03537456 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
39
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Mesoestetic Pharma Group S.L.

Collaborators